Extract from the Register of European Patents

EP About this file: EP2675487

EP2675487 - NON-INVASIVE IN VIVO METHODS OF MONITORING BIODISTRIBUTION WITH RADIOLABELED COMPOUNDS [Right-click to bookmark this link]
Former [2013/52]IN VIVO METHODS OF MONITORING BIODISTRIBUTION
[2018/15]
StatusNo opposition filed within time limit
Status updated on  23.08.2019
Database last updated on 07.03.2026
FormerThe patent has been granted
Status updated on  14.09.2018
FormerGrant of patent is intended
Status updated on  26.08.2018
FormerExamination is in progress
Status updated on  11.08.2018
FormerGrant of patent is intended
Status updated on  22.03.2018
FormerExamination is in progress
Status updated on  27.10.2017
FormerRequest for examination was made
Status updated on  01.01.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Bovin, Nicolai Vladimirovich
Artsimovicha str. 11-181
Moscow 117437 / RU
For all designated states
Henry, Stephen Micheal
3 Lonsdale Street
Ellerslie
Auckland / NZ
For all designated states
Korchagina, Elena Yurievna
Novocheremushkikaya Str. 21-1-26
Moscow 117218 / RU
For all designated states
Rodionov, Igor Leonidovich
Microdistrict "D" 1-161
Moskovskaya obl., Pushchino142292 / RU
For all designated states
Tuzikov, Alexander Borisovich
Izmailovisky pr., 47-4
Moscow 105037 / RU
[2013/52]
Inventor(s)01 / see applicant
...
 [2013/52]
Representative(s)Gowshall, Jonathan Vallance
Forresters IP LLP
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
[2018/42]
Former [2013/52]Gowshall, Jonathan Vallance
Forresters
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
Application number, filing date12755058.009.02.2012
[2018/42]
WO2012NZ00012
Priority number, dateNZ2011059104709.02.2011         Original published format: NZ 59104711
[2013/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012121610
Date:13.09.2012
Language:EN
[2012/37]
Type: A1 Application with search report 
No.:EP2675487
Date:25.12.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 13.09.2012 takes the place of the publication of the European patent application.
[2013/52]
Type: B1 Patent specification 
No.:EP2675487
Date:17.10.2018
Language:EN
[2018/42]
Search report(s)International search report - published on:AU13.09.2012
(Supplementary) European search report - dispatched on:EP15.04.2016
ClassificationIPC:A61K51/04, A61K51/08, A61K51/06, C07F9/09, C07F9/10
[2016/20]
CPC:
A61K51/0408 (EP,US); C07K7/08 (US); A61K51/08 (US);
A61K51/088 (EP,US); C07F9/10 (EP,US)
Former IPC [2013/52]A61K51/06, C07F9/09
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/52]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NICHT-INVASIVE IN-VIVO-VERFAHREN ZUR ÜBERWACHUNG EINER BIOVERTEILUNG MIT RADIOAKTIV MARKIERTEN VERBINDUNGEN[2018/15]
English:NON-INVASIVE IN VIVO METHODS OF MONITORING BIODISTRIBUTION WITH RADIOLABELED COMPOUNDS[2018/15]
French:PROCÉDÉS IN VIVO NON-INVASIFS DE SURVEILLANCE DE BIODISTRIBUTION AVEC DES COMPOSÉS RADIOMARQUÉS[2018/15]
Former [2013/52]IN-VIVO-VERFAHREN ZUR ÜBERWACHUNG EINER BIOVERTEILUNG
Former [2013/52]IN VIVO METHODS OF MONITORING BIODISTRIBUTION
Former [2013/52]PROCÉDÉS IN VIVO DE SURVEILLANCE DE BIODISTRIBUTION
Entry into regional phase09.09.2013National basic fee paid 
09.09.2013Search fee paid 
09.09.2013Designation fee(s) paid 
09.09.2013Examination fee paid 
Examination procedure09.09.2013Examination requested  [2013/52]
02.01.2017Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
13.03.2017Amendment by applicant (claims and/or description)
27.10.2017Despatch of a communication from the examining division (Time limit: M02)
05.01.2018Reply to a communication from the examining division
23.03.2018Communication of intention to grant the patent
02.08.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
02.08.2018Fee for grant paid
02.08.2018Fee for publishing/printing paid
27.08.2018Communication of intention to grant the patent
30.08.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.10.2017
Opposition(s)18.07.2019No opposition filed within time limit [2019/39]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
13.03.2017Request for further processing filed
13.03.2017Full payment received (date of receipt of payment)
Request granted
22.03.2017Decision despatched
Fees paidRenewal fee
04.04.2014Renewal fee patent year 03
21.02.2015Renewal fee patent year 04
19.02.2016Renewal fee patent year 05
14.02.2017Renewal fee patent year 06
23.02.2018Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
28.02.201403   M06   Fee paid on   04.04.2014
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.02.2012
AL17.10.2018
AT17.10.2018
CY17.10.2018
CZ17.10.2018
DK17.10.2018
EE17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
MK17.10.2018
NL17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SE17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
TR17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
LU09.02.2019
MT09.02.2019
IS17.02.2019
PT17.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
[2022/31]
Former [2021/33]HU09.02.2012
AL17.10.2018
AT17.10.2018
CY17.10.2018
CZ17.10.2018
DK17.10.2018
EE17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
NL17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SE17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
TR17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
LU09.02.2019
MT09.02.2019
IS17.02.2019
PT17.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
Former [2021/26]AL17.10.2018
AT17.10.2018
CY17.10.2018
CZ17.10.2018
DK17.10.2018
EE17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
NL17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SE17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
TR17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
LU09.02.2019
MT09.02.2019
IS17.02.2019
PT17.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
Former [2020/29]AL17.10.2018
AT17.10.2018
CZ17.10.2018
DK17.10.2018
EE17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
NL17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SE17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
TR17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
LU09.02.2019
MT09.02.2019
IS17.02.2019
PT17.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
Former [2020/17]AL17.10.2018
AT17.10.2018
CZ17.10.2018
DK17.10.2018
EE17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
NL17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SE17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
TR17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
LU09.02.2019
IS17.02.2019
PT17.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
Former [2020/12]AL17.10.2018
AT17.10.2018
CZ17.10.2018
DK17.10.2018
EE17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
NL17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SE17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
LU09.02.2019
IS17.02.2019
PT17.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
Former [2020/04]AL17.10.2018
AT17.10.2018
CZ17.10.2018
DK17.10.2018
EE17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
NL17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SE17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
LU09.02.2019
IS17.02.2019
PT17.02.2019
CH28.02.2019
LI28.02.2019
Former [2019/50]AL17.10.2018
AT17.10.2018
CZ17.10.2018
DK17.10.2018
EE17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
NL17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SE17.10.2018
SI17.10.2018
SK17.10.2018
SM17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
LU09.02.2019
IS17.02.2019
PT17.02.2019
Former [2019/47]AL17.10.2018
AT17.10.2018
CZ17.10.2018
DK17.10.2018
EE17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
NL17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SE17.10.2018
SK17.10.2018
SM17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
LU09.02.2019
IS17.02.2019
PT17.02.2019
Former [2019/45]AL17.10.2018
AT17.10.2018
CZ17.10.2018
DK17.10.2018
EE17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
MC17.10.2018
NL17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SE17.10.2018
SK17.10.2018
SM17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
Former [2019/40]AL17.10.2018
AT17.10.2018
CZ17.10.2018
DK17.10.2018
EE17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
NL17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SE17.10.2018
SK17.10.2018
SM17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
Former [2019/37]AL17.10.2018
AT17.10.2018
CZ17.10.2018
DK17.10.2018
EE17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
NL17.10.2018
PL17.10.2018
RO17.10.2018
RS17.10.2018
SE17.10.2018
SM17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
Former [2019/35]AL17.10.2018
AT17.10.2018
CZ17.10.2018
DK17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
NL17.10.2018
PL17.10.2018
RS17.10.2018
SE17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
Former [2019/34]AL17.10.2018
AT17.10.2018
DK17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
IT17.10.2018
LT17.10.2018
LV17.10.2018
NL17.10.2018
PL17.10.2018
RS17.10.2018
SE17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
Former [2019/26]AL17.10.2018
AT17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
NL17.10.2018
PL17.10.2018
RS17.10.2018
SE17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
PT17.02.2019
Former [2019/25]AT17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
NL17.10.2018
PL17.10.2018
RS17.10.2018
SE17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
Former [2019/24]AT17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
NL17.10.2018
PL17.10.2018
SE17.10.2018
BG17.01.2019
NO17.01.2019
GR18.01.2019
IS17.02.2019
Former [2019/23]AT17.10.2018
ES17.10.2018
FI17.10.2018
HR17.10.2018
LT17.10.2018
LV17.10.2018
NL17.10.2018
PL17.10.2018
BG17.01.2019
NO17.01.2019
IS17.02.2019
Former [2019/22]FI17.10.2018
LT17.10.2018
NL17.10.2018
PL17.10.2018
BG17.01.2019
NO17.01.2019
IS17.02.2019
Former [2019/21]FI17.10.2018
LT17.10.2018
NL17.10.2018
NO17.01.2019
IS17.02.2019
Former [2019/20]LT17.10.2018
NL17.10.2018
NO17.01.2019
Former [2019/17]NL17.10.2018
Documents cited:Search[X] EP0094251  (SHIONOGI & CO et al.) [X] 1,6,7 * page 1, paragraph 1 * * page 3, paragraph l * * page 8, paragraph 2 * * page 28; examples 3-2 * * pages 37-38; examples 5-2 * * page 55; examples 11-1 * * page 58; examples 11-2 * * claims 1, 3 *
 [YD] WO2009048343  (BOVIN NICOLAI et al.) [YD] 1-14 * page 1, paragraph 2 * * page 7, paragraphs 2-4 * * page 21, paragraph 2 - page 24, paragraph 2 * * page 32, paragraph 3 * * page 34, paragraph l * * page 38, paragraph 2 * * page 51, paragraph l * * page 52; figure scheme III * * claims 1, 7, 8, 10, 13-15, 20, 21, 31-33, 36, 40, 41 *
 [Y] EP0588754  (UNIV OHIO STATE RES FOUND et al.) [Y] 1-14 * page 3, lines 42-53 *
 [XPI]   ELIZABETH M HADAC ET AL: "Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simpleandbioimaging of enveloped virions", JOURNAL OF VIROLOGICAL METHODS, ELSEVIER BV, NL, vol. 176, no. 1, 7 June 2011 (2011-06-07), pages 78 - 84, XP028243695, ISSN: 0166-0934, [retrieved on 20110614], DOI: 10.1016/J.JVIROMET.2011.06.005 [XP] 1-8,11 * abstract * * figure 1 * * page 79, column 1, paragraph 1 - column 2, paragraph 1 * * page 80, column 2, paragraphs 3-4 * * page 81, column 1, paragraph 1 * * page 83, column 1, paragraph 3 * * page 83, column 2, paragraphs 2-5 * [I] 13,14

DOI:   http://dx.doi.org/10.1016/j.jviromet.2011.06.005
 [Y]   TSOMIDES T J ET AL: "Stoichiometric Labeling of Peptides by Iodination on Tyrosyl or Histidyl Residues", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS INC, NEW YORK, vol. 210, no. 1, 1 April 1993 (1993-04-01), pages 129 - 135, XP024763924, ISSN: 0003-2697, [retrieved on 19930401], DOI: 10.1006/ABIO.1993.1162 [Y] 1-14 * abstract * * page 129, column 1, paragraph 1 * * page 131, column 2, paragraph 3 - page 132, column 1, paragraph 1 *

DOI:   http://dx.doi.org/10.1006/abio.1993.1162
 [A]   D. BLAKE ET ALL: "Fluorophore-kodecytes - fluorescent function-spacer-lipid (FSL) modified cells for in vitro and in vivo analyses", FEBS JOURNAL, vol. 277, no. (Suppl 1), C3.12, 2010, pages 199 - 199, XP002756080 [A] 1-14 * abstract *
 [AD]   MASATO YAMAMOTO ET AL: "Current Issues and Future Directions of Oncolytic Adenoviruses", MOLECULAR THERAPY, vol. 18, no. 2, 24 November 2009 (2009-11-24), GB, pages 243 - 250, XP055262339, ISSN: 1525-0016, DOI: 10.1038/mt.2009.266 [AD] 1-14 * abstract * * page 246, column 2, paragraph 2 - page 247, column 1, paragraph 1 * * page 247; table 1 *

DOI:   http://dx.doi.org/10.1038/mt.2009.266
International search[XP]   HADAC, E. M. ET AL.: "Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions", JOURNAL OF VIROLOGICAL METHODS, vol. 176, 2011, pages 78 - 84, XP028243695

DOI:   http://dx.doi.org/10.1016/j.jviromet.2011.06.005
by applicant  BARR ET AL.: "Function-Spacer-Lipid (FSL) constructs enable inkjet printing of blood group antigens", FEBS J, vol. 277, no. Sl, 2010, pages 235
   BLAKE ET AL.: "Fluorophore-kodecytes - fluorescent function-spacer-lipid (FSL) modified cells for in vitro and in vivo analyses", FEBS J, vol. 277, no. Sl, 2010, pages 199, XP002756080
   CAMPOS ET AL.: "Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector", MOL THER, vol. 9, 2004, pages 942 - 954
   CHESLA ET AL.: "Solid phase syphilis test utilizing KODE technology", TRANSFUSION, vol. 50, no. Sl, 2010, pages 196A - 197A
   FRAME ET AL.: "Synthetic glycolipid modification of red blood cell membranes", TRANSFUSION, vol. 47, 2007, pages 876 - 882, XP002593488
   HADAC ET AL.: "Fluorescein and radiolabelled function-spacer-lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions", J. VIROLOGICAL METHODS, vol. 176, 2011, pages 78 - 84
   HAMMOND ET AL.: "A gama camera re-evaluation of potassium iodide blocking efficiency in mice", HEALTH PHYS, vol. 92, 2007, pages 396 - 406
   HARRISON ET AL.: "A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms", GLYCOBIOLOGY, vol. 27, 2010, pages 515 - 524, XP019818959

DOI:   http://dx.doi.org/10.1007/s10719-010-9297-y
   HEATHCOTE ET AL.: "Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto erythrocytes", TRANSFUSION, vol. 50, 2010, pages 635 - 641, XP055125525, DOI: doi:10.1111/j.1537-2995.2009.02480.x

DOI:   http://dx.doi.org/10.1111/j.1537-2995.2009.02480.x
   HENRY: "Modification of red blood cells for laboratory quality control use", CURR OPIN HEMATOL, vol. 16, 2009, pages 467 - 472
   HERMANSON: "Bioconjugation Techniques, 2nd ed.,", 2008, ACADEMIC PRESS
   HERSCHMAN: "Molecular imaging: Looking at problems, seeing solutions", SCIENCE, vol. 302, 2003, pages 605 - 608
   KAISER ET AL., ANAL. BIOCHEM., vol. 34, no. 2, 1970, pages 595 - 8
   KURUPPU; TANABE: "Viral oncolysis by herpes simplex virus and other viruses", CANCER BIOL THER, vol. 4, 2005, pages 524 - 531
   LUI ET AL.: "Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress", NAT REV CLIN ONCOL, vol. 4, 2007, pages 101 - 117, XP009100877, DOI: doi:10.1038/ncponc0736

DOI:   http://dx.doi.org/10.1038/ncponc0736
   OLIVER ET AL.: "Modeling transfusion reactions and predicting in vivo cell survival with kodecytes", TRANSFUSION, 2011
   PENG ET AL., HUM GENE THER, vol. 14, 2003, pages 1565 - 1577
   PIWNICA-WORMS ET AL.: "Molecular imaging of host-pathogen interactions in intact small animals", CELL MICROBIOL, vol. 6, 2004, pages 319 - 331
   RATY ET AL.: "Magnetic resonance imaging of viral particle biodistribution in vivo", GENE THER, vol. 13, 2006, pages 1440 - 1446
   STOKKE ET AL.: "Lipid composition and cholesterol esterification in lymph", SCAND J CLIN LAB INVEST, vol. 33, 1974, pages 199 - 206
   STRABLE; FINN: "Chemical modification of viruses and virus-like particles", CURR TOP MICROBIOL IMMUNOL, vol. 327, 2009, pages 1 - 21
   TARN: "A gradative deprotection strategy for the solid phase synthesis of peptide amides using p-(acyloxy)benzhydrylamine resin and the SN2 deprotection method", J. ORG. CHEM., vol. 50, 1985, pages 5291 - 5298
   TARN; MERRIFIELD: "The Peptides: Analysis, Synthesis, Biology", vol. 9, 1987, ACADEMIC PRESS, article "Strong acid deprotection of the synthetic peptides: mechanisms and methods", pages: 185 - 248
   WAEHLER ET AL.: "Engineering targeted viral vectors for gene therapy", NAT REV GENET, vol. 8, 2007, pages 573 - 587, XP002663591, DOI: doi:10.1038/NRG2141

DOI:   http://dx.doi.org/10.1038/NRG2141
   YAMAMOTO; CURIEL: "Current issues and future directions of oncolytic adenoviruses", MOL THER, vol. 18, 2010, pages 243 - 250, XP055262339, DOI: doi:10.1038/mt.2009.266

DOI:   http://dx.doi.org/10.1038/mt.2009.266
   YOSHIMURA; OHNISHI: "Uncoating of influenza virus in endosomes", J VIROL, vol. 51, 1984, pages 497 - 504
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.